Hartford International Opportunities HLS Fund Class IB
HBIOX
NASDAQ
| Weiss Ratings | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Hartford Mutual Funds | |||
| Manager/Tenure (Years) | Tara Connolly Stilwell (15) | |||
| Website | http://www.hartfordfunds.com | |||
| Fund Information | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Hartford International Opportunities HLS Fund Class IB | |||
| Category | Foreign Large Blend | |||
| Sub-Category | Global Equity Large Cap | |||
| Prospectus Objective | Foreign Stock | |||
| Inception Date | Apr 01, 1998 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.10% | |||
| Dividend | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.86% | |||
| Asset Allocation | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 3.60% | |||
| Stock | 96.41% | |||
| U.S. Stock | 3.56% | |||
| Non-U.S. Stock | 92.85% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.17% | |||
| 30-Day Total Return | 3.39% | |||
| 60-Day Total Return | 8.75% | |||
| 90-Day Total Return | 10.53% | |||
| Year to Date Total Return | 18.24% | |||
| 1-Year Total Return | 18.02% | |||
| 2-Year Total Return | 33.19% | |||
| 3-Year Total Return | 45.48% | |||
| 5-Year Total Return | 62.25% | |||
| Price | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $19.51 | |||
| 1-Month Low NAV | $18.87 | |||
| 1-Month High NAV | $19.51 | |||
| 52-Week Low NAV | $15.59 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $19.51 | |||
| 52-Week High Price (Date) | Jun 27, 2025 | |||
| Beta / Standard Deviation | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.00 | |||
| Standard Deviation | 16.42 | |||
| Balance Sheet | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 816.43M | |||
| Operating Ratios | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.02% | |||
| Turnover Ratio | 43.00% | |||
| Performance | HBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.74% | |||
| Last Bear Market Total Return | -14.23% | |||